← FDA DRUG APPROVALS

FDA ANDA · ANDA060347

PANMYCIN

Sponsor: PHARMACIA AND UPJOHN

APPLICATION
ANDA060347
TYPE
ANDA
ORIGINAL APPROVAL
1954-09-28
LATEST ACTION
1993-06-28
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

PANMYCINDiscontinued
TETRACYCLINE HYDROCHLORIDE 250MG · CAPSULE · ORAL

Approval history

1993-06-28Manufacturing (CMC) · Supplement 11AP
1991-07-25Labeling · Supplement 8AP
1990-12-07Labeling · Supplement 7AP
1989-02-09Manufacturing (CMC) · Supplement 9AP
1989-02-08Labeling · Supplement 10AP
1988-10-31Labeling · Supplement 6AP
1954-09-28OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →